What is the target price for organigram stock?
Their forecasts range from $2.25 to $5.30. On average, they expect OrganiGram's share price to reach $3.69 in the next year. This suggests a possible upside of 138.3% from the stock's current price. View analysts' price targets for OrganiGram or view top-rated stocks among Wall Street analysts. Who are OrganiGram's key executives?
What is the upside for organigram's stock?
Their forecasts range from C$2.25 to C$5.00. On average, they anticipate OrganiGram's share price to reach C$3.48 in the next twelve months. This suggests a possible upside of 80.3% from the stock's current price.
Is organigram's (Orgi) stock a buy or sell?
OrganiGram has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 2 buy ratings, 5 hold ratings, and 2 sell ratings. According to analysts' consensus price target of C$3.48, OrganiGram has a forecasted upside of 80.3% from its current price of C$1.93.
How much is an Ogi share worth?
One share of OGI stock can currently be purchased for approximately C$1.93. How much money does OrganiGram make? OrganiGram has a market capitalization of C$599.88 million and generates C$90.21 million in revenue each year. How many employees does OrganiGram have?
Is OGI stock a good buy?
Out of 9 analysts, 3 (33.33%) are recommending OGI as a Strong Buy, 2 (22.22%) are recommending OGI as a Buy, 4 (44.44%) are recommending OGI as a Hold, 0 (0%) are recommending OGI as a Sell, and 0 (0%) are recommending OGI as a Strong Sell. What is OGI's earnings growth forecast for 2022-2024?
What is the future of OGI stock?
OrganiGram Holdings Inc (NASDAQ:OGI) The 10 analysts offering 12-month price forecasts for OrganiGram Holdings Inc have a median target of 2.02, with a high estimate of 2.66 and a low estimate of 1.14. The median estimate represents a +80.80% increase from the last price of 1.12.
When did OGI go public?
January 5, 2012OGI stock went public on January 5, 2012 and ended the day at $0.29. The stock has since gained 1,000%. So, a $500 investment in OGI just after its IPO is currently worth $5,000. This also means that OGI stock gained a monstrous 3,800% between January 2012 and May 2019.
How many outstanding shares does OGI have?
Share StatisticsAvg Vol (3 month) 33.91MShares Outstanding 5313.71MImplied Shares Outstanding 6N/AFloat 8252.43M% Held by Insiders 118.66%7 more rows
Is OHI stock a buy or sell?
For example, a stock trading at $35 with earnings of $3 would have an earnings yield of 0.0857 or 8.57%. A yield of 8.57% also means 8.57 cents of earnings for $1 of investment....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy24.75%2Buy18.15%3Hold9.70%4Sell5.35%2 more rows
How do I buy OrganiGram stocks?
How to buy shares in OrganiGramCompare share trading platforms. Use our comparison table to help you find a platform that fits you.Open your brokerage account. Complete an application with your details.Confirm your payment details. ... Research the stock. ... Purchase now or later. ... Check in on your investment.
Who owns Ogi?
BT DE Investments Inc.
Will SNDL go up?
Sundial Growers Inc (NASDAQ:SNDL) The 3 analysts offering 12-month price forecasts for Sundial Growers Inc have a median target of 0.50, with a high estimate of 0.81 and a low estimate of 0.49. The median estimate represents a +59.27% increase from the last price of 0.31.
What is the future of HEXO?
The 7 analysts offering 12-month price forecasts for Hexo Corp have a median target of 0.19, with a high estimate of 0.39 and a low estimate of 0.12. The median estimate represents a -2.62% decrease from the last price of 0.20.
About OrganiGram
Headlines
OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. It focuses on producing cannabis for patients and adult recreational consumers. The firm's brands include Adult Recreational and Medical. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.
OrganiGram (NASDAQ:OGI) Frequently Asked Questions
CGC: Canopy Growth vs. OrganiGram: Which Cannabis Stock Is a Better Buy? - StockNews.com
Organigram Reports Highest Quarterly Net Revenue Ever In Q1, Remains Among Top Canadian Cannabis LPs
9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for OrganiGram in the last twelve months. There are currently 5 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" OrganiGram stock.
Benzinga Interview: Organigram CEO Beena Goldenberg Discusses Company Performance And Canadian Cannabis Market
Cannabis company Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) announced its results for the first quarter ended November 30, 2021.
Nasdaq Global Select
OrganiGram Holdings Inc (NASDAQ: OGI) (TSE: OGI) CEO Beena Goldenberg recently spoke with Benzinga to discuss the company's ongoing growth and Q2 success.
Environmental, Social, and Governance Rating
Based in Atlantic Canada, OrganiGram sells medical cannabis both online and via phone to individuals and physicians. The company operates five healing centers for post-traumatic stress disorder treatment, chronic pain, trauma therapy, and medical cannabis as an alternative medicine.
Business Summary
"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
Should I hold Organigram stock?
Based in Atlantic Canada, OrganiGram sells medical cannabis both online and via phone to individuals and physicians. The company operates five healing centers for post-traumatic stress disorder treatment, chronic pain, trauma therapy, and medical cannabis as an alternative medicine.
Is Organigram a hold?
The consensus among Wall Street analysts is that investors should "hold" OrganiGram stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OGI, but not buy additional shares or sell existing shares.
What is the parent company of Organigram?
Wall Street analysts have given OrganiGram a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but OrganiGram wasn't one of them.
What is Organigram Holdings?
Organigram Holdings Inc. ( NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today it will report earnings results for its third quarter Fiscal 2021 ended May 31, 2021 on Tuesday July 13, 2021 before market open.
